National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

October 4, 2024

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 89 Issue 193 (Friday, October 4, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 193 (Friday, October 4, 2024)]
[Notices]
[Pages 80905-80906]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-22981]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose

[[Page 80906]]

confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the cooperative agreement applications, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Clinical Trial Planning Grant 
(R34); Investigator Initiated Extended Clinical Trial (R01); 
Clinical Trial Implementation Cooperative Agreement (U01); SBIR 
Phase II Clinical Trial Implementation Cooperative Agreement (U44).
    Date: October 29, 2024.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3F40A, 
Rockville, MD 20892 (Video Assisted Meeting).
    Contact Person: Robert C. Unfer, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3F40A, 
Rockville, MD 20892, (240) 669-5035, <a href="/cdn-cgi/l/email-protection#dba9b4b9bea9aff5aeb5bdbea99bb5b2b3f5bcb4ad"><span class="__cf_email__" data-cfemail="8efce1ecebfcfaa0fbe0e8ebfccee0e7e6a0e9e1f8">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: October 1, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-22981 Filed 10-3-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on October 4, 2024.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.